Skip to main content
. 2022 Aug 11;13:866252. doi: 10.3389/fendo.2022.866252

Table 3.

Methodology of urinary exosome extraction and characterization in eligible studies.

Study Sample Urinary EV isolation methods Characterization
TEM NTA WB
Benito-Martin, 2013 (44) Morning urine with protease inhibitors cocktail Ultracentrifugation + DTT * TSG101, CD63
Shankhajit De, 2017 (45) Fresh second urine with protease inhibitors Ultracentrifugation + CD63 or CD81 isolation kit (Invitrogen) * * CD81, TSG101, ALIX
Gudehithlu, 2015 (47) Fresh urine sample (50–100mL) with 2.5 mM DTT and protease inhibitors cocktail Ultracentrifugation
Kalani, 2013 (36) Spot urine Ultracentrifugation TSG101
Sakurai, 2019 (46) Urine samples (50–150 mL) Sucrose density gradients+ ultracentrifugation CD63, CD81, CD9
Sun, 2012 (40) 24-hour urine Immunoprecipitation *
Zubiri, 2015 (38) Urine with protease inhibitors cocktail DTT+ ultracentrifugation+
depleted albumin and IgG using ProteoPrep Immunoaffinity Albumin and IgG Depletion Kit (Sigma)
* Alix, calnexin
Zubiri, 2014 (39) Second-morning urine with a protease-inhibitors cocktail Comparison of three methods:
①ultracentrifugation ②DTT+ ultracentrifugation
③Exoquick® commercial reagent
Comparison of three commercial kits to deplete high abundance protein:
①Albumin Removal SwellGel Discs (Pierce)
②Albusorb® (Biotech Support Group)
③ProteoPrep® Immunoaffinity Albumin & IgG Depletion Kit
* Alix, TSG101, Calnexin
Kaminska,2016 (13) First-morning urine (50mL) Ultracentrifugation *
Luca Musante, 2015 (37) First-morning void urine (15mL) Hydrostatic filtration dialysis TSG101
Wu Fan, 2018 (41) 24-hour urine Hydrostatic filtration dialysis * * TSG101
Wang Lili, 2020 (42) First-morning urine (100mL) 0.22μm filtration + ultracentrifugation * TSG101, CD63
Chen Zhengxu, 2021 (43) First-morning urine (10mL) Exoquick® commercial reagent

*: The method of characterization had been conducted.